Bastide le Confort Medical S.A.

Bastide le Confort Medical S.A.

0IP1 · LSE

20.05EUR+0.43 (+2.17%)

Price History

Full chart

Market Stats

Previous Close19.62
Open20.05
Day Range20.05 – 20.05
52-Week Range19.04 – 27.45
Volume80
Market Cap182.04M
P/E (TTM)0.00
Forward P/E0.00
EPS1.83
Dividend Yield0.00%
Beta0.89
50-Day Avg21.98
200-Day Avg25.17

About

Bastide Le Confort Médical SA, together with its subsidiaries, engages in the sale and rental of medical equipment in France, the United Kingdom, Belgium, Spain, Canada, the Netherlands, and Italy. It operates in six segments: Respiratory Assistance, Home Care, Healthcare Facilities, Nutrition/Infusion/Diabetes, Stoma Therapy/Urology/Wound Care, and E-commerce. The company offers reclining chairs, lift chairs, and accessories and tables for armchairs; incontinence products, including sample wait, slip absorbent, adult complete change, incontinence diapers, and onesies, anatomical, male urinary, and right-hand protections, incontinence panties and swimsuits, disposable bed pads, support briefs, slips filets, feminine hygiene products, hygiene incontinence, and washable and reusable briefs and panties for urinary incontinence; and mobility products, such as walkers and rollators, walking sticks, electric scooters, and manual and electric wheelchairs. It also provides medical equipment comprising heating products, bathroom medical equipment, medical measuring device, medical pillow and cushion, technical support, electrostimulation and circulatory stimulators, pressotherapy device, pedal exerciser for seniors, seniors' telephone, bedside tables, medicalized room, sleep apnea device, natural food supplement, thermal compresses, pedicure and foot care, comfort shoes, first aid products, and wellness and health. In addition, the company offers professional equipment, which includes consumable for healthcare professionals, hygiene and disinfection, care and dressings, diagnosis and self-checking, and other medical equipment; and rental and services for medical bed, wheelchair, air mattress, patient lift, and verticalizer. It exports its products. The company was incorporated in 1976 and is headquartered in Caissargues, France. Bastide Le Confort Médical SA operates as a subsidiary of Societe d'Investissement Bastide SAS.

Company Details

Leadership

  • Mr. Vincent BastideChairman & CEO
  • Mr. Arnaud FayolleDeputy Chief Executive Officer
  • Pierre-Marie VarachaudDeputy Chief Executive Officer
  • Mr. Jeremy LugagneDeputy Chief Executive Officer
  • Mr. Benjamin FerreDeputy Chief Executive Officer

Financials

Income Statement

Currency: EUR2008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-30
Total Revenue94.84M96.79M99.95M109.13M123.57M134.05M152.13M171.17M191.85M218.11M289.05M335.73M382.71M444.07M468.30M508.03M529.75M491.18M
Growth (%)-+2.06%+3.26%+9.18%+13.23%+8.48%+13.49%+12.51%+12.08%+13.69%+32.53%+16.15%+13.99%+16.04%+5.46%+8.48%+4.28%-7.28%
Cost of Revenue35.15M37.94M38.92M41.76M45.53M49.01M53.97M60.23M67.25M75.44M103.69M114.94M131.10M163.81M161.50M174.30M482.92M443.04M
Gross Profit59.69M58.85M61.03M67.37M78.04M85.04M98.16M110.94M124.60M142.66M185.36M220.79M251.61M280.26M306.80M333.73M46.83M48.14M
Gross Margin62.94%60.80%61.06%61.73%63.15%63.44%64.52%64.81%64.95%65.41%64.13%65.76%65.74%63.11%65.51%65.69%8.84%9.80%
Operating Expense49.84M54.31M54.82M60.82M70.39M76.41M87.13M97.85M110.81M130.76M166.05M193.39M217.92M242.76M267.87M290.91M2.61M3.92M
Operating Income9.86M4.55M6.21M6.55M7.65M8.63M11.03M13.09M13.80M11.90M19.30M27.39M33.69M37.50M38.93M42.82M44.22M44.22M
Operating Margin10.39%4.70%6.21%6.01%6.19%6.43%7.25%7.65%7.19%5.46%6.68%8.16%8.80%8.45%8.31%8.43%8.35%9.00%
EBITDA17.95M13.90M15.88M16.93M19.51M22.01M26.82M31.91M35.02M36.38M49.42M63.55M66.67M80.19M79.51M82.36M107.20M101.42M
EBITDA Margin18.92%14.36%15.89%15.52%15.79%16.42%17.63%18.64%18.25%16.68%17.10%18.93%17.42%18.06%16.98%16.21%20.24%20.65%
Net Income5.89M2.24M2.85M3.20M3.52M4.13M5.12M6.80M7.18M5.42M7.16M4.57M11.60M13.45M13.68M16.07M-900.00K528.00K
Net Income Margin6.21%2.32%2.86%2.93%2.85%3.08%3.36%3.97%3.74%2.49%2.48%1.36%3.03%3.03%2.92%3.16%-0.17%0.11%
R&D---------------41.00K--
R&D as % of Total Revenue---------------0.01%--
Interest Expense829.00K1.03M1.11M1.05M1.29M1.47M1.70M1.97M2.05M3.03M5.14M8.51M10.49M9.22M12.78M16.59M27.37M31.87M
Interest Expense % of Total Revenue0.87%1.06%1.11%0.96%1.05%1.10%1.12%1.15%1.07%1.39%1.78%2.53%2.74%2.08%2.73%3.27%5.17%6.49%

Balance Sheet

Currency: EUR2008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-30
Total Assets73.68M79.26M83.49M96.40M104.22M115.02M137.30M159.78M188.49M257.74M383.91M395.67M506.00M569.11M632.55M657.08M647.07M661.03M
Total Liabilities37.98M42.48M44.26M55.13M60.93M68.52M86.98M105.33M129.27M195.19M314.68M329.23M426.38M484.05M545.89M568.99M566.34M589.73M
Total Equity35.71M36.78M39.23M41.03M43.17M46.39M50.22M53.63M58.75M61.92M66.69M63.45M75.67M81.31M84.56M87.65M79.77M72.13M
Cash1.66M237.00K977.00K4.59M4.17M3.90M3.38M4.68M19.88M14.44M28.68M21.34M35.42M33.74M22.13M36.71M23.62M25.49M
Total Debt12.46M23.17M27.47M29.11M31.55M34.55M48.60M60.25M77.87M131.76M215.46M213.45M306.29M357.62M419.23M427.39M408.65M411.16M
Net Debt10.80M22.94M26.49M24.52M27.38M30.66M45.21M55.57M57.99M117.32M186.78M192.11M270.87M323.88M397.10M390.69M385.03M385.67M

Cash Flow

Currency: EUR2008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-30
Operating Cash Flow11.73M442.00K16.53M14.47M17.21M19.30M18.20M24.26M31.58M26.47M50.41M61.02M39.61M66.13M46.76M90.28M66.04M71.87M
Investing Cash Flow-10.99M-10.09M-9.91M-17.11M-15.76M-19.48M-29.44M-27.92M-26.26M-76.07M-104.17M-51.56M-50.55M-73.45M-104.74M-76.27M-43.65M-56.44M
Financing Cash Flow814.00K4.47M-3.24M6.68M-2.93M144.00K8.53M3.48M4.79M51.20M71.05M-22.07M25.87M9.65M39.81M7.53M-35.55M-4.33M
Capital Expenditure10.72M10.60M9.79M13.40M14.29M17.93M25.22M25.75M22.64M27.03M38.28M34.37M39.79M46.51M53.27M53.63M55.40M60.08M
Free Cash Flow1.01M-10.16M6.74M1.07M2.93M1.38M-7.02M-1.49M8.94M-559.00K12.13M26.65M-179.00K19.62M-6.51M36.65M10.64M11.79M
Dividends Paid-----1.31M1.38M1.61M1.83M1.91M1.99M1.91M69.00K2.14M2.24M613.00K1.63M569.00K
FCF to OCF8.63%-2298.42%40.77%7.41%17.00%7.12%-38.55%-6.12%28.31%-2.11%24.06%43.67%-0.45%29.67%-13.93%40.59%16.12%16.41%
Dividend Paid to FCF-----95.42%-19.60%-108.75%20.52%-340.79%16.43%7.16%-38.55%10.92%-34.36%1.67%15.30%4.83%

Key Statistics & Ratios

Market Cap182.04M
Enterprise Value441.41M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.36
Price / Book0.00
EPS1.83
Book Value13.86
Revenue (TTM)510.46M
Gross Profit (TTM)344.00M
EBITDA86.56M
Profit Margin5.77%
Operating Margin10.09%
Return on Equity11.56%
Return on Assets4.75%
Shares Outstanding7.32M
Shares Float3.39M
Beta0.89
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20221×
0.27Jan 7, 2022
20211×
0.27Jan 7, 2021
20181×
0.26Dec 7, 2018
20171×
0.26Dec 18, 2017
20161×
0.26Dec 15, 2016
20151×
0.25Dec 15, 2015
20141×
0.22Dec 15, 2014